These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 32266504)

  • 21. Evaluation of preoperative prognostic factors in patients with resectable pancreatic ductal adenocarcinoma.
    Izumo W; Higuchi R; Furukawa T; Yazawa T; Uemura S; Shiihara M; Yamamoto M
    Scand J Gastroenterol; 2019 Jun; 54(6):780-786. PubMed ID: 31180790
    [No Abstract]   [Full Text] [Related]  

  • 22. Prognostic Impact of Radiological Splenic Artery Involvement in Pancreatic Ductal Adenocarcinoma of the Body and Tail.
    Kitamura K; Esaki M; Sone M; Sugawara S; Hiraoka N; Nara S; Ban D; Takamoto T; Mizui T; Shimada K
    Ann Surg Oncol; 2022 Oct; 29(11):7047-7058. PubMed ID: 35691957
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical impacts of resection margin status and clinicopathologic parameters on pancreatic ductal adenocarcinoma.
    Jamiyan T; Shiraki T; Kurata Y; Ichinose M; Kubota K; Imai Y
    World J Surg Oncol; 2020 Jun; 18(1):137. PubMed ID: 32571348
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Resectable pancreatic adenocarcinoma: Role of CT quantitative imaging biomarkers for predicting pathology and patient outcomes.
    Cassinotto C; Chong J; Zogopoulos G; Reinhold C; Chiche L; Lafourcade JP; Cuggia A; Terrebonne E; Dohan A; Gallix B
    Eur J Radiol; 2017 May; 90():152-158. PubMed ID: 28583627
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intravoxel incoherent motion DWI of the pancreatic adenocarcinomas: monoexponential and biexponential apparent diffusion parameters and histopathological correlations.
    Ma C; Li Y; Wang L; Wang Y; Zhang Y; Wang H; Chen S; Lu J
    Cancer Imaging; 2017 Apr; 17(1):12. PubMed ID: 28454564
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DeepPrognosis: Preoperative prediction of pancreatic cancer survival and surgical margin via comprehensive understanding of dynamic contrast-enhanced CT imaging and tumor-vascular contact parsing.
    Yao J; Shi Y; Cao K; Lu L; Lu J; Song Q; Jin G; Xiao J; Hou Y; Zhang L
    Med Image Anal; 2021 Oct; 73():102150. PubMed ID: 34303891
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Extrapancreatic Nerve Plexus Invasion on Imaging Predicts Poor Survival After Upfront Surgery for Anatomically Resectable Pancreatic Cancer.
    Sugimoto M; Kobayashi T; Kobayashi S; Takahashi S; Konishi M; Mitsunaga S; Ikeda M; Gotohda N
    Pancreas; 2020; 49(5):675-682. PubMed ID: 32433406
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of Response to Neoadjuvant Therapy Using CT Texture Analysis in Patients With Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma.
    Borhani AA; Dewan R; Furlan A; Seiser N; Zureikat AH; Singhi AD; Boone B; Bahary N; Hogg ME; Lotze M; Zeh HJ; Tublin ME
    AJR Am J Roentgenol; 2020 Feb; 214(2):362-369. PubMed ID: 31799875
    [No Abstract]   [Full Text] [Related]  

  • 29. Ovarian Metastasis from Pancreatic Ductal Adenocarcinoma.
    Habib JR; Pasha S; Khan S; Kinny-Köster B; Shoucair S; Thompson ED; Yu J; Lafaro K; Burkhart RA; Burns WR; Ronnett BM; Wolfgang CL; Hruban RH; He J; Fishman EK; Javed AA
    World J Surg; 2021 Oct; 45(10):3157-3164. PubMed ID: 34236477
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preoperative evaluation of pancreatic ductal adenocarcinoma with synchronous liver metastasis: Diagnosis and assessment of unresectability.
    Shi HJ; Jin C; Fu DL
    World J Gastroenterol; 2016 Dec; 22(45):10024-10037. PubMed ID: 28018110
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A nomogram based on preoperative inflammatory markers predicting the overall survival of pancreatic ductal adenocarcinoma.
    Xu J; Shi KQ; Chen BC; Huang ZP; Lu FY; Zhou MT
    J Gastroenterol Hepatol; 2017 Jul; 32(7):1394-1402. PubMed ID: 27973703
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Impact of Tumor Location on Resection and Survival for Pancreatic Ductal Adenocarcinoma.
    Winer LK; Dhar VK; Wima K; Morris MC; Lee TC; Shah SA; Ahmad SA; Patel SH
    J Surg Res; 2019 Jul; 239():60-66. PubMed ID: 30802706
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of the prognostic impact of pre- and post-operative CA19-9, SPan-1, and DUPAN-II levels in patients with pancreatic carcinoma.
    Kondo N; Murakami Y; Uemura K; Nakagawa N; Takahashi S; Ohge H; Sueda T
    Pancreatology; 2017; 17(1):95-102. PubMed ID: 27746094
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nonhypervascular pancreatic neuroendocrine tumors: Spectrum of MDCT imaging findings and differentiation from pancreatic ductal adenocarcinoma.
    Karmazanovsky G; Belousova E; Schima W; Glotov A; Kalinin D; Kriger A
    Eur J Radiol; 2019 Jan; 110():66-73. PubMed ID: 30599875
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic value of γ-glutamyltransferase-to-albumin ratio in patients with pancreatic ductal adenocarcinoma following radical surgery.
    Li S; Xu H; Wu C; Wang W; Jin W; Gao H; Li H; Zhang S; Xu J; Zhang W; Xu S; Li T; Ni Q; Yu X; Liu L
    Cancer Med; 2019 Feb; 8(2):572-584. PubMed ID: 30632317
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neutrophil-lymphocyte ratio (NLR) was associated with prognosis and immunomodulatory in patients with pancreatic ductal adenocarcinoma (PDAC).
    Xiang ZJ; Hu T; Wang Y; Wang H; Xu L; Cui N
    Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32510138
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic value of the preoperative fibrinogen-to-albumin ratio in pancreatic ductal adenocarcinoma patients undergoing R0 resection.
    Zhang LP; Ren H; Du YX; Wang CF
    World J Gastroenterol; 2020 Dec; 26(46):7382-7404. PubMed ID: 33362391
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Systematic review and meta-analysis comparing the surgical outcomes of invasive intraductal papillary mucinous neoplasms and conventional pancreatic ductal adenocarcinoma.
    Koh YX; Chok AY; Zheng HL; Tan CS; Goh BK
    Ann Surg Oncol; 2014 Aug; 21(8):2782-800. PubMed ID: 24687151
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Important CT and histopathological findings for recurrence and overall survival in patients with pancreatic ductal adenocarcinoma who underwent surgery after neoadjuvant FOLFIRINOX.
    Park SJ; Kim JH; Joo I; Lee KB; Han JK
    Eur Radiol; 2021 Jun; 31(6):3616-3626. PubMed ID: 33201279
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nonhypervascular Pancreatic Neuroendocrine Tumors: Differential Diagnosis from Pancreatic Ductal Adenocarcinomas at MR Imaging-Retrospective Cross-sectional Study.
    Jeon SK; Lee JM; Joo I; Lee ES; Park HJ; Jang JY; Ryu JK; Lee KB; Han JK
    Radiology; 2017 Jul; 284(1):77-87. PubMed ID: 28092495
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.